Evidence map›Paper›PMID 39444288›Full record

ArticleInternational journal of technology assessment in health care2024

Perceptions of patients and caregivers toward the management of rare disease in Malaysia: a qualitative research study.

Azuwana Supian, Asrul A Shafie, Lock-Hock Ngu, Hatijah Ayob, Nathorn Chaiyakunapruk

Abstract read
In one paragraph

Article in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Azuwana SupianPharmaceutical Services Programme, Hospital Tuanku Ja'afar Seremban, Ministry of Health Malaysia, Malaysia.ORCID https://orcid.org/0000-0002-8587-1934
Asrul A ShafieDiscipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.ORCID https://orcid.org/0000-0002-5629-9270
Lock-Hock NguGenetic Clinic, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.ORCID https://orcid.org/0000-0002-2396-1686
Hatijah AyobMalaysian Rare Disorders Society, Petaling Jaya, Malaysia.
Nathorn ChaiyakunaprukDepartments College of Pharmacy, University of Utah, Salt Lake City, UT, USA.ORCID https://orcid.org/0000-0003-4572-8794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe management of rare diseases is rarely addressed among policymakers and public communities. It is hindered by the lack of information on its epidemiology and burden, especially from the perspective of patients and families with rare diseases. This study aims to understand the perceptions of rare disease patients and their families in the management of rare diseases in Malaysia. METHODOLOGY: A qualitative interview was used to explore the perceptions of patients and families regarding the management of rare diseases in Malaysia. In-depth interviews were conducted with the rare disease patients or their parents/guardians provided by three major rare disease advocacy groups, between 1 July and 15 September 2016. The interviews focused on two key areas: the challenges associated with rare disease and the issues related to accessing medication.

findingsOut of the nineteen recruited participants, seventeen (89.5 percent) completed the interview sessions. The significance of awareness, knowledge, and support from others emerged as crucial for families and patients living with rare diseases. Despite facing delayed diagnosis and treatment, a majority of patients and parents expressed satisfaction with the advancements in rare disease management. Nevertheless, a prominent challenge revolves around access to enzyme replacement therapy for eligible patients.

conclusionThis study emphasizes the importance of healthcare professionals understanding patient with rare diseases perceptions to tailor communication strategies, provide accurate information, and address concerns effectively. The message underscores the significance of collaboration between healthcare providers and patient support groups to deliver adequate health information, potentially enhancing patients' understanding and their illness perceptions.

Indexed as

CaregiversQualitative ResearchRare DiseasesAdultFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansInterviews as TopicMalaysiaMaleMiddle AgedParentsPerceptionaccess to medicineMalaysiaorphan drugpatients’ perceptionrare disease

Identifiers

PMID39444288
PMCPMC11569895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.